Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. . 2022, , 1115-1126.

Curr Issues Mol Biol

Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, West Yorkshire, UK.

Published: April 2022

Aldén et al. (2022) conducted research showing that the Pfizer BioNTech COVID-19 mRNA vaccine, BNT162b2, can undergo reverse transcription inside human liver cells in a lab setting.
The study used a specific human liver cell line called Huh7 to observe this process.
This finding raises questions about the potential cellular interactions and mechanisms involved with mRNA vaccines, which could have implications for understanding their effects in the body.

Aldén et al. (2022) recently reported the intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 in vitro in a human liver cell line (Huh7) [...].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164063	PMC
http://dx.doi.org/10.3390/cimb44040113	DOI Listing

Publication Analysis

Top Keywords

intracellular reverse

reverse transcription

transcription pfizer

pfizer biontech

biontech covid-19

covid-19 mrna

mrna vaccine

vaccine bnt162b2

bnt162b2 vitro

vitro human

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!